Only a small percentage of recently listed biotech and healthcare companies have posted share price gains in the past year, highlighting the risk of investing in the sector. Belite Bio, however, a ...

Vor Bio (NASDAQ:VOR) stock rallied 64% in post-market trading Thursday after the company reported positive data for its gene-edited stem cell therapy trem-cel in the treatment of acute myeloid ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Bio-Oil is probably the first skincare product ...

Bio-Rad Laboratories, Inc. BIO is expected to release first-quarter 2024 results on May 2 after the closing bell. The company posted adjusted earnings per share (EPS) of $3.10 in the last reported ...

Climb Bio licenses CLYM116, an anti-APRIL antibody, expanding its immune-mediated disease pipeline, with preclinical data expected in 2025. Climb Bio, Inc. has announced an exclusive licensing ...

WASHINGTON, DC—Using an implantable cardiac monitor (ICM) to look for arrhythmias after an MI—and initiate treatment as appropriate—does not provide a significant clinical benefit, according to the ...

Users of the Zuckerberg-owned app can now add direct links to their Insta profiles without relying on Linktree and other third parties. Reading time 2 minutes Instagram has caved to years of creator ...